Development
Dyne Therapeutics, Inc.
DYN
$11.59
$1.1210.70%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -10.68% | 7.23% | -46.88% | -13.80% | 6.18% |
| Total Depreciation and Amortization | -7.42% | 0.00% | 4.61% | 2.74% | 1.01% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 21.96% | 1.02% | -3.30% | 17.41% | 22.17% |
| Change in Net Operating Assets | 467.31% | 7.17% | 153.01% | -253.63% | 200.02% |
| Cash from Operations | 30.82% | 9.06% | -18.62% | -60.69% | 31.80% |
| Capital Expenditure | 50.90% | 33.20% | -8.70% | 55.68% | 41.42% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 102.33% | -25.71% | -35.94% | 38.15% | -62.40% |
| Cash from Investing | 104.32% | -25.60% | -36.32% | 40.68% | -62.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -67.62% | -98.18% | -13.57% | -22.55% | 53,047.14% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -67.62% | -98.18% | -13.57% | -22.55% | 53,047.14% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 76.79% | -176.41% | -250.56% | -67.08% | 205.37% |